These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37645033)

  • 1. Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive-compulsive disorder in patients with bipolar disorder: Double-blind, randomized clinical trial.
    Khorshidian F; Hamidia A; Kheirkhah F; Moghadamnia AA; Bijani A; Mirtabar SM; Koutanaei SJ
    Health Sci Rep; 2023 Aug; 6(8):e1531. PubMed ID: 37645033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder.
    Di Salvo G; Maina G; Pessina E; Teobaldi E; Barbaro F; Martini A; Albert U; Rosso G
    Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374357
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and familial profile of bipolar disorder with and without obsessive-compulsive disorder: an Indian study.
    Kazhungil F; Cholakottil A; Kattukulathil S; Kottelassal A; Vazhakalayil R
    Trends Psychiatry Psychother; 2017; 39(4):270-275. PubMed ID: 29267510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is deep brain stimulation effective and safe for patients with obsessive compulsive disorder and comorbid bipolar disorder?
    Graat I; van Rooijen G; Mocking R; Vulink N; de Koning P; Schuurman R; Denys D
    J Affect Disord; 2020 Mar; 264():69-75. PubMed ID: 31846903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of adjunctive low-frequency repetitive transcranial magnetic stimulation therapy over the left dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder refractory to medical treatment:A double-blind, randomized clinical trial.
    Jahanbakhsh G; Alireza Haji Seyed Javadi S; Majidi M; Khademi M; Karimi R
    Asian J Psychiatr; 2023 Feb; 80():103384. PubMed ID: 36565659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
    Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
    Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
    Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
    BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid obsessive compulsive disorder in patients with bipolar-I disorder.
    Shashidhara M; Sushma BR; Viswanath B; Math SB; Janardhan Reddy YC
    J Affect Disord; 2015 Mar; 174():367-71. PubMed ID: 25545603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of preschool children with obsessive compulsive disorder.
    Inci Izmir SB; Ercan ES
    Clin Child Psychol Psychiatry; 2023 Apr; 28(2):734-747. PubMed ID: 35801811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).
    Sayyah M; Sayyah M; Boostani H; Ghaffari SM; Hoseini A
    Depress Anxiety; 2012 Oct; 29(10):850-4. PubMed ID: 22933237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical expression of obsessive-compulsive disorder in women with bipolar disorder.
    Issler CK; Amaral JA; Tamada RS; Schwartzmann AM; Shavitt RG; Miguel EC; Lafer B
    Braz J Psychiatry; 2005 Jun; 27(2):139-42. PubMed ID: 15962140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
    Ak M; Bulut SD; Bozkurt A; Ozsahin A
    Adv Ther; 2011 Apr; 28(4):341-8. PubMed ID: 21437763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile.
    de Filippis R; Aloi M; Bruni A; Gaetano R; Segura-Garcia C; De Fazio P
    J Affect Disord; 2018 Aug; 235():1-6. PubMed ID: 29627704
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.